Yang Ling

621 citations
24 papers · 504 · h-index 14

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Wnt/β-catenin signaling in development and cancer
    • Circular RNAs in diseases
    • Cancer-related gene regulation
    • Epigenetics and DNA Methylation
    • RNA modifications and cancer
    • RNA Research and Splicing

Papers in

    • Epigenetics and DNA Methylation 7
    • Cancer-related gene regulation 6
    • Retinoids in leukemia and cellular processes 3
    • Circular RNAs in diseases 3
    • MicroRNA in disease regulation 4
    • Cancer-related molecular mechanisms research 4
    • Cancer, Hypoxia, and Metabolism 3

Yang Ling

23 papers receiving 497 citations

Peers

Yang Ling
Comparison fields: 5 of 88
  • Cancer Research 161
  • Molecular Biology 355
  • Oncology 102
  • Immunology and Allergy 14
  • Cell Biology 34
Replace Amy M. Jefferson with:
Amy M. Jefferson United States
Mengdi Yang China
Ning Zou China
Lian Tang China
Huiran Lin China
Xiaofeng Cai United States
Fangfang Yang China
Xiaoping Wan China
Yang Ling relative to Amy M. Jefferson United States Amy M. Jefferson's profile →
Citations per field
00.5×2.6×
Amy M. Jefferson · 1×
Citations per year

Countries citing papers authored by Yang Ling

Since Specialization
Citations

This map shows the geographic impact of Yang Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Ling more than expected).

Fields of papers citing papers by Yang Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Ling. The network helps show where Yang Ling may publish in the future.

Co-authors

The 25 scholars most cited alongside Yang Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yang Ling Line = papers co-authored together Yang Ling links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201299
2 201273
3 201239
4 202038
5 201535
6 201728
7 201924
8 201423
9 201122
10 201717
11 201316
12 200915
13 201314
14 201213
15 201812
16 20147
17 20166
18 20155
19 20215
20 20214

About Yang Ling

Yang Ling is a scholar working on Molecular Biology, Cancer Research, Genetics, Immunology and Surgery, having authored 24 papers that have together received 504 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (7 papers), Cancer-related gene regulation (6 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Retinoids in leukemia and cellular processes (3 papers), Circular RNAs in diseases (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Glioma Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (161 citations), Molecular Biology (355 citations), Oncology (102 citations), Immunology and Allergy (14 citations) and Cell Biology (34 citations). Yang Ling has collaborated with scholars based in China and United States. Frequent co-authors include Liang Chen, Jun Du, Jiaojing Liu, Yichao Zhu, Luo Gu, Zhenzhen Hu, Changsong Zhang, Lixin Wei, Yong Liu and Jianzhong Xu. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Journal of Biochemical and Molecular Toxicology, International Journal of Biological Sciences, Diseases of the Esophagus and Annals of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact